Will LymPro really work and bring in the needed re
Post# of 30028
Posted On: 08/11/2014 6:19:19 PM
Re: DandyRitter #3595
Will LymPro really work and bring in the needed revenue to make the company grow and fund MANF? This is the vision we longs either believe in or we don't.
BECKTON DICKENSON: The fact that AMBS chose to have one of the most reputable diagnostic companies in the world VALIDATE LymPro's science speaks volumes of the wisdom of Gerald and his Dad John. (As well as the other Scientific Advisors) Having BD validate LymPro meant AMBS wanted to do things right. They wanted to be able to face the toughest scrutiny of the scientific community regarding LymPro's efficacy and not blink!! That is what Gerald did do in Copenhagen and at #C4CT. AMBS presented posters and data that caught the attention of the scientific community. Gerald has avoided, to our frustration at times, going out and promoting LymPro before he had taken it through all the steps required by the scientific community and announcing it was the real deal. Gerald has shown great maturity and patience, which I attribute to his Dad, in the way he has brought LymPro forward. You don't just announce your product is worthy of being the "industry standard" until it has methodically proven it. Otherwise, you're viewed as an upstart. Gerald has been careful to avoid that. Some shareholders on the mb think of him as an upstart, but I don't.
Having Beckton Dickenson's name on those posters in Copenhagen was HUGE!! It comforts me.
DIAGNOSTIC EXPERTS COMING TO LAUNCH LYMPRO: Over the past 6 months or so Gerald has brought on some terrific diagnostic talent. Why would these people come on unless they felt LymPro merited risking their careers for? The data presented thus far suggests LymPro is the real deal and these experts very presence at AMBS doubly confirms this to me.
NUMEROUS INDEPENDENT SCIENTISTS ARE VALIDATING MANF: The fact that Maart Sarma in Helsinki and Dr. Urano have both tested MANF in diabetes research and found that it stops the progress of diabetes is astonishing! The PR this morning about the Buck Institute is just one of many more independent groups around the world that are validating the effectiveness of MANF. This is mind boggling! The dozens and dozens of possible MANF indications means it could permanently change medicine.
MEETING GERALD FACE TO FACE THREE TIMES: I have peppered Gerald three times with many questions about everything in the company. That's what I do. He answered those questions articulately and politely and I found him to be very much in command of the facts and his vision for the company was powerful. I pride myself in being able to read people. If Gerald were a flim flam man I would have seen and felt it. He isn't! He is a good man that has surrounded himself with the greatest scientific, diagnostic, & financial talent that there is. If I didn't like what I heard from him in our three visits, (30 to 50 minutes each) I would have come back to the message board and crucified him! But I didn't. He's a great man and I completely trust him.
These are the reasons I believe AMBS is going to succeed. I hope they help you in your dd. Good luck.
BECKTON DICKENSON: The fact that AMBS chose to have one of the most reputable diagnostic companies in the world VALIDATE LymPro's science speaks volumes of the wisdom of Gerald and his Dad John. (As well as the other Scientific Advisors) Having BD validate LymPro meant AMBS wanted to do things right. They wanted to be able to face the toughest scrutiny of the scientific community regarding LymPro's efficacy and not blink!! That is what Gerald did do in Copenhagen and at #C4CT. AMBS presented posters and data that caught the attention of the scientific community. Gerald has avoided, to our frustration at times, going out and promoting LymPro before he had taken it through all the steps required by the scientific community and announcing it was the real deal. Gerald has shown great maturity and patience, which I attribute to his Dad, in the way he has brought LymPro forward. You don't just announce your product is worthy of being the "industry standard" until it has methodically proven it. Otherwise, you're viewed as an upstart. Gerald has been careful to avoid that. Some shareholders on the mb think of him as an upstart, but I don't.
Having Beckton Dickenson's name on those posters in Copenhagen was HUGE!! It comforts me.
DIAGNOSTIC EXPERTS COMING TO LAUNCH LYMPRO: Over the past 6 months or so Gerald has brought on some terrific diagnostic talent. Why would these people come on unless they felt LymPro merited risking their careers for? The data presented thus far suggests LymPro is the real deal and these experts very presence at AMBS doubly confirms this to me.
NUMEROUS INDEPENDENT SCIENTISTS ARE VALIDATING MANF: The fact that Maart Sarma in Helsinki and Dr. Urano have both tested MANF in diabetes research and found that it stops the progress of diabetes is astonishing! The PR this morning about the Buck Institute is just one of many more independent groups around the world that are validating the effectiveness of MANF. This is mind boggling! The dozens and dozens of possible MANF indications means it could permanently change medicine.
MEETING GERALD FACE TO FACE THREE TIMES: I have peppered Gerald three times with many questions about everything in the company. That's what I do. He answered those questions articulately and politely and I found him to be very much in command of the facts and his vision for the company was powerful. I pride myself in being able to read people. If Gerald were a flim flam man I would have seen and felt it. He isn't! He is a good man that has surrounded himself with the greatest scientific, diagnostic, & financial talent that there is. If I didn't like what I heard from him in our three visits, (30 to 50 minutes each) I would have come back to the message board and crucified him! But I didn't. He's a great man and I completely trust him.
These are the reasons I believe AMBS is going to succeed. I hope they help you in your dd. Good luck.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼